Sterling Capital Management LLC Sells 3,049 Shares of Axon Enterprise, Inc $AXON

Sterling Capital Management LLC lessened its position in Axon Enterprise, Inc (NASDAQ:AXON) by 15.5% in the second quarter, Holdings Channel.com reports. The firm owned 16,645 shares of the biotechnology company’s stock after selling 3,049 shares during the quarter. Sterling Capital Management LLC’s holdings in Axon Enterprise were worth $13,781,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of AXON. Jennison Associates LLC increased its stake in shares of Axon Enterprise by 23,203.7% in the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock valued at $322,961,000 after buying an additional 611,418 shares during the period. Nuveen LLC bought a new stake in shares of Axon Enterprise in the first quarter worth $264,796,000. McElhenny Sheffield Capital Management LLC acquired a new stake in Axon Enterprise in the second quarter valued at $255,833,000. Westfield Capital Management Co. LP increased its holdings in Axon Enterprise by 29.8% in the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after purchasing an additional 212,931 shares during the period. Finally, Vanguard Group Inc. raised its position in Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock worth $4,540,005,000 after purchasing an additional 185,571 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AXON has been the subject of several recent research reports. Piper Sandler decreased their price target on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research note on Wednesday. JMP Securities reissued a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Needham & Company LLC restated a “buy” rating and set a $870.00 price target on shares of Axon Enterprise in a report on Wednesday, September 24th. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. Finally, Bank of America lifted their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $810.71.

Insider Activity

In related news, CFO Brittany Bagley sold 5,000 shares of the firm’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the transaction, the chief executive officer owned 3,053,982 shares of the company’s stock, valued at $2,538,744,696.78. This trade represents a 0.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 59,932 shares of company stock valued at $45,115,616. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Stock Down 8.2%

AXON stock opened at $587.14 on Friday. The stock’s 50 day simple moving average is $722.51 and its 200 day simple moving average is $734.37. The company has a market cap of $46.09 billion, a P/E ratio of 144.97, a price-to-earnings-growth ratio of 29.49 and a beta of 1.45. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a fifty-two week low of $462.81 and a fifty-two week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, November 4th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. During the same quarter in the prior year, the firm earned $1.45 EPS. The company’s revenue was up 30.6% compared to the same quarter last year. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.